BAYER AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.58 EUR | -0.24% |
|
-1.30% | -15.02% |
| May. 17 | BAYER AG : UBS remains Neutral | ZD |
| May. 17 | IQ-AI Unit Delivers Software to Insel Gruppe | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 47.17B 51.26B | Sales 2025 * | 47.88B 52.03B | Capitalization | 28.08B 30.51B |
|---|---|---|---|---|---|
| Net income 2024 * | 2.36B 2.56B | Net income 2025 * | 3.18B 3.46B | EV / Sales 2024 * | 1.28 x |
| Net Debt 2024 * | 32.4B 35.21B | Net Debt 2025 * | 30.17B 32.79B | EV / Sales 2025 * | 1.22 x |
| P/E ratio 2024 * |
12.4
x | P/E ratio 2025 * |
8.76
x | Employees | 98,189 |
| Yield 2024 * |
0.38% | Yield 2025 * |
0.78% | Free-Float | 99.97% |
More Fundamentals
* Assessed data
More news
Latest transcript on Bayer AG
More news
| 1 day | -0.24% | ||
| 1 week | -1.30% | ||
| Current month | +4.50% | ||
| 1 month | +8.88% | ||
| 3 months | -0.10% | ||
| 6 months | -31.05% | ||
| Current year | -15.02% |
1 week
28.41
30.41
1 month
25.6130.41
Current year
24.9636.09
1 year
24.9654.95
3 years
24.9667.99
5 years
24.9678.34
10 years
24.96146.45
| Managers | Title | Age | Since |
|---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 57 | 23-03-31 |
| Director of Finance/CFO | 55 | 18-04-25 | |
Bijoy Sagar
CTO | Chief Tech/Sci/R&D Officer | 55 | 20-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Colleen Goggins
BRD | Director/Board Member | 68 | 17-03-31 |
Alberto Weisser
BRD | Director/Board Member | 67 | 21-03-31 |
Paul Achleitner
BRD | Director/Board Member | 67 | 02-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 9.77% | 70 M€ | -.--% | - | |
| 5.71% | 2 M€ | +13.56% | - | |
| 4.28% | 962 M€ | -.--% | - | |
| 4.10% | 0 M€ | 0.00% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 28.58 | -0.24% | 2,757,036 |
| 24-05-16 | 28.65 | -2.30% | 4,713,509 |
| 24-05-15 | 29.32 | +0.36% | 3,645,309 |
| 24-05-14 | 29.22 | -0.54% | 7,096,306 |
| 24-05-13 | 29.38 | +1.47% | 3,538,582 |
Delayed Quote Xetra, May 17, 2024 at 11:37 am EDT
More quotes
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
28.58
EUR
Average target price
36.9
EUR
Spread / Average Target
+29.13%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -15.02% | 30.53B | |
| +32.09% | 693B | |
| +29.39% | 584B | |
| -1.34% | 372B | |
| +20.34% | 332B | |
| +7.39% | 294B | |
| +14.25% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +8.49% | 168B |
- Stock Market
- Equities
- BAYN Stock
